Activation of human dendritic cells through CD40 cross-linking
暂无分享,去创建一个
J. Banchereau | C. Caux | C. van Kooten | B. Vanbervliet | C. Kooten | C. Massacrier | B. Dubois | I. Durand | atrice Vanbervliet
[1] R. Noelle,et al. CD40 and its ligand. , 1996, Advances in immunology.
[2] J. Banchereau,et al. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells , 1994, The Journal of experimental medicine.
[3] J. Banchereau,et al. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40 , 1994, European journal of immunology.
[4] L. Lanier,et al. CD40 preferentially costimulates activation of CD4+ T lymphocytes. , 1994, Journal of immunology.
[5] A. Aruffo,et al. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39 , 1993, The Journal of experimental medicine.
[6] A. Aruffo,et al. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions , 1993, The Journal of experimental medicine.
[7] O. Stutman,et al. Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation. , 1993, Journal of immunology.
[8] K. Kishi,et al. Induction of human IgE synthesis in B cells by mast cells and basophils , 1993, Nature.
[9] R. Steinman,et al. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium , 1993, Journal of Experimental Medicine.
[10] W. Fanslow,et al. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40 , 1993, The Journal of experimental medicine.
[11] J. Banchereau,et al. Human B cell precursors proliferate and express CD23 after CD40 ligation , 1993, The Journal of experimental medicine.
[12] G. Aversa,et al. The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation , 1993, The Journal of experimental medicine.
[13] E. Roldán,et al. Essential role of tumor necrosis factor‐α in the differentiation of human tonsil in vivo induced B cells capable of spontaneous and high‐rate immunoglobulin secretion , 1993, European journal of immunology.
[14] C. Hsieh,et al. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.
[15] I. Stamenkovic,et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[16] A. Fischer,et al. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM , 1993, Nature.
[17] L. Notarangelo,et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM , 1993, Nature.
[18] J. Bajorath,et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome , 1993, Cell.
[19] J. Banchereau,et al. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells , 1992, Nature.
[20] P. Cruz,et al. Cytokine expression by epidermal cell subpopulations. , 1992, The Journal of investigative dermatology.
[21] H. Spits,et al. CD40 is functionally expressed on human thymic epithelial cells. , 1992, Journal of immunology.
[22] J. Abrams,et al. Strategies of Anti‐Cytokine Monoclonal Antibody Development: Immunoassay of IL‐10 and IL‐5 in Clinical Samples , 1992, Immunological reviews.
[23] L. Notarangelo,et al. Immunodeficiency with hyper-IgM (HIM). , 1992, Immunodeficiency reviews.
[24] A. Aruffo,et al. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. , 1992, Immunology today.
[25] J. Banchereau,et al. Potentiation of early hematopoiesis by tumor necrosis factor-alpha is followed by inhibition of granulopoietic differentiation and proliferation. , 1991, Blood.
[26] J. Banchereau,et al. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen , 1991, The Journal of experimental medicine.
[27] R. Steinman,et al. The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.
[28] R. Geha,et al. CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells , 1990, The Journal of experimental medicine.
[29] J. Larrick,et al. Cytotoxic mechanism of tumor necrosis factor‐α , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] R. Steinman,et al. Migration and maturation of Langerhans cells in skin transplants and explants , 1990, The Journal of experimental medicine.
[31] R. Steinman,et al. Use of the fluorescence activated cell sorter to enrich dendritic cells from mouse spleen. , 1990, Journal of immunological methods.
[32] R. Steinman,et al. The distinct surface of human blood dendritic cells, as observed after an improved isolation method. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Banchereau,et al. mAb 104, a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-1-transformed T cells. , 1990, Immunology.
[34] P. Peters,et al. Human epidermal Langerhans cells undergo profound morphologic and phenotypical changes during in vitro culture. , 1990, The Journal of investigative dermatology.
[35] O. Majdic,et al. Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. , 1989, The Journal of investigative dermatology.
[36] J. Banchereau,et al. Activation of human B lymphocytes through CD40 and interleukin 4 , 1989, European journal of immunology.
[37] I. Stamenkovic,et al. A B‐lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. , 1989, The EMBO journal.
[38] E. Clark,et al. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. , 1986, Proceedings of the National Academy of Sciences of the United States of America.